semaglutide vs tirzepitide Tirzepatide: Which GLP-1 Wins for Weight Loss? Semaglutide vs. Tirzepatide: Which is

Mu Y, Gage FH

Bifidobacteria have demonstrated to reduce inflammation in different in vivo models

For patients, the implications are far-reaching

The SELECT cardiovascular outcomes trial (Lincoff et al., 2023, New England Journal of Medicine) enrolled 17,604 adults with obesity and established cardiovascular disease no diabetes, and demonstrated a 20% reduction in major adverse cardiovascular events (MACE) with 2.4mg semaglutide versus placebo

49,50 In this trial exenatide was safe and well-tolerated, with no withdrawals due to drug adverse effects

This triple action may offer more significant results compared to existing medications, providing a comprehensive approach to weight management